Profil is an internationally renowned CRO in the field of metabolic diseases, founded in 1999. For many years, we have been working closely with the pharmaceutical industry to develop new drugs for the treatment of diabetes and related diseases. We also intensively support the further development of known active substances. Furthermore, we conduct vital research regarding various other exciting applications such as novel routes of insulin administration or the measurement of blood glucose concentrations. Our many years of experience have enabled us to build up comprehensive sc...